{"id":7301,"date":"2023-07-07T11:57:18","date_gmt":"2023-07-07T09:57:18","guid":{"rendered":"https:\/\/myruns.com\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/"},"modified":"2025-02-04T17:17:51","modified_gmt":"2025-02-04T16:17:51","slug":"myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels","status":"publish","type":"post","link":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/","title":{"rendered":"Myruns becomes majority partner in Evolgene Genomics to advance biomaterials and biofuels"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene-1024x576.jpg\" alt=\"\" class=\"wp-image-6355\" srcset=\"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene-1024x576.jpg 1024w, https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene-980x552.jpg 980w, https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene-480x270.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n\n<p class=\"wp-block-paragraph\">Myruns has acquired 80% of the shares of <strong>Evolgene Genomics<\/strong>, a leading spin-off of the renowned cooperative nanoscience research center located in Guipuzcoa, CIC nanoGUNE.<\/p>\n\n<p class=\"wp-block-paragraph\">Evolgene&#8217;s expertise lies in the reconstruction of ancestral sequences (ASR) with the aim of producing enzymes with extraordinary properties, using ancestral cellulases and xylanases. The company has a portfolio of ancestral enzymes with a wide range of biotechnological and industrial applications. It has also developed a novel and innovative process to produce cellulose nanocrystals without the need to use hazardous chemicals. All this, together with its experience and in-depth knowledge of designing and selecting enzymes with improved properties, has made Evolgene a particularly attractive company in the technology development sector.<\/p>\n\n<p class=\"wp-block-paragraph\">With this strategic acquisition, the main objective of both companies is to join forces to advance biomass treatment, the development of high value-added biomaterials and the creation of new generation biofuels, thus contributing to the production of clean and sustainable energy.<\/p>\n\n<p class=\"wp-block-paragraph\">This collaboration is nothing new in the industry, as Evolgene and Myruns, as a company specializing in radio frequency technology (RFID), have already been working together for many years. <span style=\"text-decoration: underline;\"><strong><a href=\"https:\/\/www.myruns.com\/empresa\/\">company specializing in radio frequency technology (RFID), have worked together on previous projects<\/a><\/strong><\/span>We have worked together on projects before, achieving exceptional results in technological development. Our collaboration has resulted in the filing of six revolutionary and successful patents, enabling the use of conductive inks in RFID tags, as well as the introduction of a highly disruptive technology never seen before: the replacement of metals with a conductive ink. These advances have far-reaching economic implications, as they can be applied in various sectors, such as cosmetics, pharmaceuticals and electronics.  <\/p>\n\n<p class=\"wp-block-paragraph\">This exciting step forward for science ensures a bright and promising future for both technologies, for innovation and for the advancement of the biotechnology industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Myruns has acquired 80% of the shares of Evolgene Genomics, a leading spin-off of the renowned cooperative nanoscience research center located in Guipuzcoa, CIC nanoGUNE. Evolgene&#8217;s expertise lies in the reconstruction of ancestral sequences (ASR) with the aim of producing enzymes with extraordinary properties, using ancestral cellulases and xylanases. The company has a portfolio of [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":6993,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-7301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-myruns-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myruns becomes majority shareholder of Evolgene Genomics<\/title>\n<meta name=\"description\" content=\"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myruns becomes majority shareholder of Evolgene Genomics\" \/>\n<meta property=\"og:description\" content=\"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/\" \/>\n<meta property=\"og:site_name\" content=\"Myruns RFID\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-07T09:57:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-04T16:17:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jose\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jose\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/\"},\"author\":{\"name\":\"Jose\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/#\\\/schema\\\/person\\\/3e4c120aa29481a7ed3cea36768b3029\"},\"headline\":\"Myruns becomes majority partner in Evolgene Genomics to advance biomaterials and biofuels\",\"datePublished\":\"2023-07-07T09:57:18+00:00\",\"dateModified\":\"2025-02-04T16:17:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/\"},\"wordCount\":311,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/myruns.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/myruns-evolgene.jpg\",\"articleSection\":[\"Myruns News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/\",\"url\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/\",\"name\":\"Myruns becomes majority shareholder of Evolgene Genomics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/myruns.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/myruns-evolgene.jpg\",\"datePublished\":\"2023-07-07T09:57:18+00:00\",\"dateModified\":\"2025-02-04T16:17:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/#\\\/schema\\\/person\\\/3e4c120aa29481a7ed3cea36768b3029\"},\"description\":\"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#primaryimage\",\"url\":\"https:\\\/\\\/myruns.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/myruns-evolgene.jpg\",\"contentUrl\":\"https:\\\/\\\/myruns.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/myruns-evolgene.jpg\",\"width\":1080,\"height\":608},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/2023\\\/07\\\/07\\\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/myruns.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myruns becomes majority partner in Evolgene Genomics to advance biomaterials and biofuels\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/myruns.com\\\/en\\\/\",\"name\":\"Myruns RFID\",\"description\":\"Empresa dedicada al desarrollo de producto RFID\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/myruns.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myruns.com\\\/en\\\/#\\\/schema\\\/person\\\/3e4c120aa29481a7ed3cea36768b3029\",\"name\":\"Jose\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g\",\"caption\":\"Jose\"},\"url\":\"https:\\\/\\\/myruns.com\\\/en\\\/author\\\/jose\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myruns becomes majority shareholder of Evolgene Genomics","description":"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/","og_locale":"en_US","og_type":"article","og_title":"Myruns becomes majority shareholder of Evolgene Genomics","og_description":"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.","og_url":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/","og_site_name":"Myruns RFID","article_published_time":"2023-07-07T09:57:18+00:00","article_modified_time":"2025-02-04T16:17:51+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg","type":"image\/jpeg"}],"author":"Jose","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jose","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#article","isPartOf":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/"},"author":{"name":"Jose","@id":"https:\/\/myruns.com\/en\/#\/schema\/person\/3e4c120aa29481a7ed3cea36768b3029"},"headline":"Myruns becomes majority partner in Evolgene Genomics to advance biomaterials and biofuels","datePublished":"2023-07-07T09:57:18+00:00","dateModified":"2025-02-04T16:17:51+00:00","mainEntityOfPage":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/"},"wordCount":311,"commentCount":0,"image":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#primaryimage"},"thumbnailUrl":"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg","articleSection":["Myruns News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/","url":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/","name":"Myruns becomes majority shareholder of Evolgene Genomics","isPartOf":{"@id":"https:\/\/myruns.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#primaryimage"},"image":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#primaryimage"},"thumbnailUrl":"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg","datePublished":"2023-07-07T09:57:18+00:00","dateModified":"2025-02-04T16:17:51+00:00","author":{"@id":"https:\/\/myruns.com\/en\/#\/schema\/person\/3e4c120aa29481a7ed3cea36768b3029"},"description":"Myruns has acquired 80% of the shares of Evolgene , a spin-off of the renowned cooperative nanoscience research center.","breadcrumb":{"@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#primaryimage","url":"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg","contentUrl":"https:\/\/myruns.com\/wp-content\/uploads\/2023\/07\/myruns-evolgene.jpg","width":1080,"height":608},{"@type":"BreadcrumbList","@id":"https:\/\/myruns.com\/en\/2023\/07\/07\/myruns-becomes-majority-partner-in-evolgene-genomics-to-advance-biomaterials-and-biofuels\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/myruns.com\/en\/"},{"@type":"ListItem","position":2,"name":"Myruns becomes majority partner in Evolgene Genomics to advance biomaterials and biofuels"}]},{"@type":"WebSite","@id":"https:\/\/myruns.com\/en\/#website","url":"https:\/\/myruns.com\/en\/","name":"Myruns RFID","description":"Empresa dedicada al desarrollo de producto RFID","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/myruns.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/myruns.com\/en\/#\/schema\/person\/3e4c120aa29481a7ed3cea36768b3029","name":"Jose","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/127545612df57006a8a6a52e0d681fd8eee2f4b4d3527e7ee032d10f4d642d6d?s=96&d=mm&r=g","caption":"Jose"},"url":"https:\/\/myruns.com\/en\/author\/jose\/"}]}},"_links":{"self":[{"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/posts\/7301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/comments?post=7301"}],"version-history":[{"count":3,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/posts\/7301\/revisions"}],"predecessor-version":[{"id":7984,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/posts\/7301\/revisions\/7984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/media\/6993"}],"wp:attachment":[{"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/media?parent=7301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/categories?post=7301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myruns.com\/en\/wp-json\/wp\/v2\/tags?post=7301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}